Kendrith Rowland, MD

Physician, Medical Oncology

National Cancer Institute Community Oncology Research Program (NCORP), Principal Investigator
Breast cancer

Fellowship, Rush Medical Center, Chicago, IL, 1983-1985
Residency, University of Illinois Hospital, Chicago, IL,
MD, University of Illinois Abraham Lincoln School of Medicine, Chicago, IL, 1980

Clark AS, Zhao F, Klein P, Montero AJ, Falkson C, Krill-Jackson E, Rowland K, Sardesai S, Incorvati J, Dillon P, Wolff AC, Trauger R, Heineman TC, Coffey MC, Miller KD. A Phase II Randomized Study of Paclitaxel alone or combined with Pelareorep with or without Avelumab in Metastatic Hormone Receptor Positive Breast Cancer: the BRACELET-01/PrE0113 study. Clin Cancer Res. 2025 Apr 29. doi: 10.1158/1078-0432.CCR-24-2701. Online ahead of print. PMID: 40300087.
Carter J, Pugh SL, Arring N, Littell RD, Page SJ, Rowland KM Jr, Goodman JR, Razaq W, Siddique S, Borges M, Kachnic LA, Barton DL. NRG-CC004 ancillary data sutdy-exploring the effect of bupropion on sexual desire in female cancer survivors with and without vulvovaginal symptoms. J Sex Med. 2024 Aug 1;21(8):709-715. doi: 10.1093/jsxmed/qdae061. PMID: 38856026.
Rapp SR, Dressler EV, Brown WM, Wade JL 3rd, Le-Lindqwister N, King D, Rowland KM, Weaver KE, Klepin HD, Shaw EG, Lesser GJ. Phase III Randomized, Placebo-Controlled Clinical Trial of Donzepezil for Treatment of Cognitive Impairment in Breast Cancer Survivors After Adjuvent Chemotherapy (WF-97116). J Clin Oncol. 2024 Jul 20;42(21):2546-2557. doi: 10.1200/JCO.23.01100. Epub 2024 May 6. PMID: 38709986.